|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-1268-2023 - Atellica CH LDL Cholesterol Direct (DLDL)-In vitro diagnostic quantitative determination of LDL cholesterol in human serum and plasma (lithium heparin) using the Atellica CH Analyzer.
SMN: 11097632
|
2
|
08/29/2023
|
Siemens Healthcare Diagnostics, Inc.
|
Z-1271-2023 - Atellica CH Triglycerides_2: in vitro diagnostic use in the
quantitative determination of triglycerides in human serum and plasma (lithium heparin,
sodium heparin, potassium EDTA) using the Atellica C...
|
2
|
08/29/2023
|
Siemens Healthcare Diagnostics, Inc.
|
Z-1270-2023 - Atellica CH Triglycerides (concentrated)-In vitro diagnostic use
in the quantitative measurement of triglycerides in human serum and plasma (lithium
heparin, potassium EDTA) using the Atellica CH Anal...
|
2
|
08/29/2023
|
Siemens Healthcare Diagnostics, Inc.
|
Z-1269-2023 - Atellica CH Total Protein II- In vitro diagnostic use in the quantitative determination of total protein in human serum and plasma (lithium heparin) using the Atellica CH Analyzer.
SMN: 11097604
|
2
|
08/29/2023
|
Siemens Healthcare Diagnostics, Inc.
|